Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355,  NDC 42023-179-05
Agency: FDA
Recall date: 2026-06-12
Recalling firm: Par Health USA, LLC

Crystallization; identified as Buprenorphine free base

Hazard: Crystallization; identified as Buprenorphine free base
Severity: Class II
Distribution: Nationwide in the USA.